Orally administered cortisone in erythema nodosum. 1952

S J SCHNEIERSON

UI MeSH Term Description Entries
D003348 Cortisone A naturally occurring glucocorticoid that has been used in replacement therapy for ADRENAL INSUFFICIENCY and as an anti-inflammatory agent. Cortisone itself is inactive; it is converted in the liver to the active metabolite HYDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726) 17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate,Adreson,Cortisone Acetate,Cortone Acetate
D004893 Erythema Nodosum An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.

Related Publications

S J SCHNEIERSON
April 1956, Therapie der Gegenwart,
S J SCHNEIERSON
September 1951, A.M.A. archives of internal medicine,
S J SCHNEIERSON
April 1951, Journal des praticiens; revue generale de clinique et de therapeutique,
S J SCHNEIERSON
November 1955, The Journal of the American Osteopathic Association,
S J SCHNEIERSON
November 1951, California medicine,
S J SCHNEIERSON
November 1953, New York state journal of medicine,
S J SCHNEIERSON
October 1950, Science (New York, N.Y.),
S J SCHNEIERSON
January 1951, Bulletin de l'Academie nationale de medecine,
S J SCHNEIERSON
April 1954, La Presse medicale,
S J SCHNEIERSON
November 1951, A.M.A. archives of dermatology and syphilology,
Copied contents to your clipboard!